SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Array Biopharma, Inc
An SI Board Since March 2005
Posts SubjectMarks Bans Symbol
321 29 0 ARRY
Emcee:  keokalani'nui Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
146(some authors in common)......... Cancer Biol Ther. 2012 Apr 1;13(6). [Epub ahscaram(o)uche-2/10/2012
145Hi MCBIO, I am after “cash burning small bios” for last 20 years, and it isMiljenko Zuanic32/10/2012
144The financing was prudent management, nothing else.tom pope-2/9/2012
143Everyone should do what works for them and what they are comfortable with, of comcbio-2/9/2012
142I am out. Will revisit in one/two years, or if price drop below $1.5/share. EOMMiljenko Zuanic12/9/2012
141<<Let's hope this leads to a partnership negotiation from a stronger pMiljenko Zuanic12/8/2012
140"Near-term I think there is some dilution risk as ARRY will likely have totuck-2/8/2012
139Biotech Stocks To Watch In 2012 [SeekingAlpha] February 6, 2012 Array Biophasim1-2/6/2012
138Anticancer Drugs. 2012 Jan 29. [Epub ahead of print] A prolonged complete respscaram(o)uche-2/3/2012
137I am bit reserved that today bounce is due to PI confirmation for 162, from NovaMiljenko Zuanic-1/31/2012
136slide 6...... media.corporate-ir.netscaram(o)uche-1/31/2012
135Have no real world position here (but a small chunk in my charity portfolio), antuck-1/31/2012
134Neuroscience. 2012 Jan 10. [Epub ahead of print] Selective inhibition of extrascaram(o)uche-1/29/2012
133<<Near-term I think there is some dilution risk as ARRY will likely have tMiljenko Zuanic11/24/2012
132Thanks for the response. I did catch that article you reference and I take it amcbio-1/23/2012
131Just want to share bit of the info on MEK-path inhibitors. First (as disclosureMiljenko Zuanic-1/23/2012
130Thanks! (eom)scaram(o)uche-1/19/2012
1291 CR in biliary per the ASCO GI abstract ( siliconinvestor.com ).mcbio-1/18/2012
128When the ceo quits, I expect the stock drop, not the opposite. Makes me wonder fred hayes-1/18/2012
127Array's CEO Bob Conway resigns after 12 years with company Headquartered isim1-1/18/2012
126Hope that he and family are healthy/good. Thanks, Tuck. Rickscaram(o)uche-1/17/2012
125Conway just fired himself for personal reasons. Cheers, Tucktuck-1/17/2012
124$150m mixed shelf. The Board continues to give out bonuses to management. fiscaram(o)uche-11/23/2011
123Clin Endocrinol Metab. 2011 Nov 16. [Epub ahead of print] The Akt Inhibitor MKscaram(o)uche-11/19/2011
122going over older pubcrawls, thought this might interest some....... Nat Genet.scaram(o)uche-11/8/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News